1) Novel clinical studies with CAR-T Cellular Immunotherapy in refractory lymphomas 2) Clinical trials in acute and chronic Graft Versus Host Disease 3) Mismatched Unrelated Allogeneic Stem Cell Transplantation 4) Prevention and Treatment of post-transplant relapse of leukemias and lymphomas.
Management of relapsed leukemias, lymphomas and myelomas. Prevention and management of Graft versus Host Disease, Conditioning chemotherapy before stem cell transplants, Cancer Immunology.